association

Full identifier: http://purl.org/np/RA1mFMDNtnDJcNuxY-I2uLbZZwMf6HW2ZiZ1fInDzI2dE#association

Assigned to 1 class:

Minted in Nanopublication

 RA1mFMDNtn comment approve/disapprove edit as derived nanopublication create new with same template

This is the identifier for this whole nanopublication. http://purl.org/np/RA1mFMDNtn... This nanopublication date and time when the nanopublication was created http://purl.org/dc/terms/created was created on (this is a literal) "2021-08-23T19:06:18.192+02:00" .
This is the identifier for this whole nanopublication. http://purl.org/np/RA1mFMDNtn... This nanopublication links to the assertion template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate was created from the assertion template http://purl.org/np/RAhNHZw6Ur... RAhNHZw6Ur .
This is the identifier for this whole nanopublication. http://purl.org/np/RA1mFMDNtn... This nanopublication links to the provenance template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate was created from the provenance template http://purl.org/np/RANwQa4ICW... RANwQa4ICW .
This is the identifier for this whole nanopublication. http://purl.org/np/RA1mFMDNtn... This nanopublication links to the publication info template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate was created from the publication info template http://purl.org/np/RAA2MfqdBC... RAA2MfqdBC .

References

Nanopublication Part Subject Predicate Object Published By Published On
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-08-23T17:06:18.192Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
"Ibandronate sodium is contraindicated in patients with the following conditions: * Abnormalities of the esophagus which delay esophageal emptying such as stricture or achalasia (see Warnings and Precautions [ 5.1 * Inability to stand or sit upright for at least 60 minutes (see Dosage and Administration [2.2], and Warnings and Precautions [ 5.1 * Hypocalcemia (see Warnings and Precautions [ 5.2 * Known hypersensitivity to ibandronate sodium tablets or to any of its excipients. Cases of anaphylaxis have been reported. (see Adverse Reactions [6.2]) * Abnormalities of the esophagus which delay esophageal emptying such as stricture or achalasia ( 4 5.1 * Inability to stand or sit upright for at least 60 minutes ( 4 5.1 * Hypocalcemia ( 4 * Hypersensitivity to ibandronate sodium ( 4"
Leoni Bücken
2021-08-23T17:06:18.192Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-08-23T17:06:18.192Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-08-23T17:06:18.192Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-08-23T17:06:18.192Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-08-23T17:06:18.192Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-08-23T17:06:18.192Z

Raw

TriG(txt), JSON-LD(txt), N-Quads(txt), XML(txt)